A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
about
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopeniaLong-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology.Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study.Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.Association of primary biliary cirrhosis with idiopathic thrombocytopenic purpuraAutoimmune thrombocytopenia related to chronic hepatitis C virus infection.Pathobiology of secondary immune thrombocytopenia.Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection.Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia.Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction.Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation.Detection of circulating B cells producing anti-GPIb autoantibodies in patients with immune thrombocytopeniaAbnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV-related liver disease.Platelet IgG antibodies are significantly increased in chronic liver diseaseNo sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial.Management of thrombocytopenia in advanced liver diseaseImmunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis.Thrombocytopenia in chronic liver disease.From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.New insights into the coagulopathy of liver disease and liver transplantationHypersplenism: History and current status.Management of coagulation abnormalities in liver disease.How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?Platelets as Modulators of Liver Diseases.
P2860
Q27488342-F246D588-9EE0-4F19-881D-516E1B800D17Q30665307-5491518A-24AA-4334-89F6-DF14811290C3Q33368703-5C2173C4-8C72-4AC7-A8B6-C74BF99E1D09Q33372582-686BE852-A65B-48AF-B04E-C13D332FB465Q33372989-D4CF1D31-1EFB-4FC6-8533-FB5618EF847EQ33373813-18D2C61F-D8B7-4144-8D95-80E977F528D1Q33376165-47022BC2-8C31-41C4-A7F5-6E4B1EE3D057Q33379289-5CC41429-7645-4AF1-892D-9B5E39928741Q33382854-1DAEC7AB-4378-4BCD-8AA0-3A35A58EC635Q33383468-39F01A89-254C-4E4E-85AE-3759E2AC2523Q33386712-942F00FC-DF98-491E-98E1-4EB2CCC41DE8Q33398338-57024D7D-BC98-4A97-8661-6453745356AFQ33410431-5143B417-2AD9-4EED-A7B5-B420192D9782Q33411544-8BC531E9-BC55-459A-B0E0-24C21639E070Q33412917-3AB81357-AC12-4EAE-8DEE-16704853343DQ33413800-CDCFC59B-6F5C-4A80-9746-8969CD54A4B3Q33414506-655D1372-8D29-4A44-9C29-93ACA5A17152Q33417539-B108F654-F3B9-404F-BDC2-9390ED32EE3EQ33417667-8ED9A220-BD21-47A2-A84D-D2C86A5F1CF8Q33418708-D32EC492-67F5-4331-903E-4B517A5DCA6DQ33425621-8480A2F4-4FB8-42D2-B299-632889BF76EAQ33427048-64F6A132-7D1E-461B-BC5C-7399AF42B3B2Q33436901-5B2AF0B9-FC4B-4D23-905F-7E3F49BB5E46Q33436905-5996102F-40A7-4A42-AD1B-287AEF19CE95Q33441627-7E93C885-7921-4807-962B-36F024C62D0AQ33866656-17B5E113-91FB-4BD3-ADE6-7ED27C2ECB25Q37289448-C9BC1C33-E7BF-4561-AFDD-EB28E12C4683Q38223728-2F4B534D-AD05-4378-836B-DAB5C65B6E89Q39997164-B4ECAB87-68AA-40B9-AC79-740E40ACC75EQ50131013-747EDD8B-904A-4662-A929-2B888FF1E448
P2860
A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@ast
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@en
type
label
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@ast
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@en
prefLabel
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@ast
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@en
P2093
P356
P1433
P1476
A role of autoantibody-mediate ...... ia in patients with cirrhosis.
@en
P2093
Hiromasa Ishii
Masataka Kuwana
Mikio Kajihara
Shinzo Kato
Yasuo Ikeda
Yutaka Kawakami
P304
P356
10.1053/JHEP.2003.50209
P407
P50
P577
2003-06-01T00:00:00Z